Allogeneic Hematopoietic Stem Cell Transplant (HSCT) for Patients in the 6th and 7th Decades of Life with AML or MDS Using Myeloablative, Reduced Toxicity IV Busulfan/Fludarabine (BuFlu) Conditioning Regimen

✍ Scribed by G. Alatrash; B. Andersson; M. Pelosini; G. Rondon; M. Qazilbash; S. Giralt; L. de Padua Silva; C. Hosing; P. Kebriaei; W. Zhang; R. Saliba; R. Champlin; M. de Lima

• Book ID: 116280828
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 53 KB
• Volume: 15
• Category: Article
• ISSN: 1083-8791
• DOI: 10.1016/j.bbmt.2008.12.327